Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
Submitted by
admin
on February 23, 2018 - 7:51am
Source:
CP Wire
News Tags:
BASF
Hepaxa
DIEM Labs
non-alcoholic fatty liver disease
drug launches
Headline:
BASF launches Hepaxa as first dedicated product in the U.S. to help patients manage Non-Alcoholic Fatty Liver Disease
Do Not Allow Advertisers to Use My Personal information
